Season 1 · Episode 368
Ep. 378: Mark Lichtenfeld on Biotech, Income Investments and a 2016 Forecast
Wall Street Unplugged - What's Really Moving These Markets · Frank Curzio
January 6, 201638m 17s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Marc Lichtenfeld, chief income strategist at the Oxford Club, editor of the Oxford Income Letter and host of Mark Lichtenfeld’s Oxford Club Radio podcast, shares his best ideas on the upcoming JP Morgan Healthcare Conference that he’ll be attending next week. Marc breaks down the biotech industry. This is a sector of the market he's been covering for over a decade. Marc talks about these early stage companies that have huge upside potential. As Mark say’s, “It’s important to keep your emotions in check and your positions sizes small when you’re investing in these startups.” Switching gears Mark gives us his forecast for 2016. You won’t want to miss this. And finally Mark covers those stocks he looks at for generating safe income. He like the big healthcare companies, especially big pharmaceuticals and he gives us one of his best new recommendations that almost no one else is looking at.